Additional information
| Active substance | Mazdutide |
|---|---|
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring blood glucose levels and HbA1c |
| Also known as | LY3298176 |
| Blood pressure | May reduce blood pressure |
| Trade name | Mounjaro |
| FORM | 1 vial x 10 mg |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F), protect from light |
| Chemical name | Tirzepatide |
| Formula | C225H348N48O68 |
| Substance class | Glucagon-like peptide-1 (GLP-1) receptor agonists |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 5 days |
| Dosage (medical) | Typically started at 2.5 mg once weekly, can be increased to 5 mg, 10 mg, or 15 mg once weekly depending on response and tolerability |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Improves glycemic control, promotes weight loss |
| Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation |
| Use in sports | None, not used for performance enhancement |
| Manufacturer | Dragon Pharma |
Oral Cycle Ultima Pharmaceuticals
PRIMO - K KASSEL
Zostum-O 200 mg Zuventus Healthcare Ltd.
Olympus Labs Ep1logue 60kaps Olympus Labs
T3 KASSEL
Zimaks Bilim
Febutaz 40 mg Sun Pharmaceuticals Industries
Metenolone Acetate HEMI PHARMA
ImuneksPlus IMUNEKS FARMA
T3bolic Cooper Pharma 

Reviews
There are no reviews yet.